elemene has been researched along with Laryngeal Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tao, L; Zhou, L | 1 |
Tao, L; Yao, M; Zheng, L; Zhou, L | 1 |
Tao, L; Yao, M; Zheng, LY; Zhou, L | 1 |
Cao, Z; Ji, W | 1 |
4 other study(ies) available for elemene and Laryngeal Neoplasms
Article | Year |
---|---|
[Study on the expression of eIF families after elemene treatment].
Topics: Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Fibroblast Growth Factor 2; Humans; Laryngeal Neoplasms; Sesquiterpenes; Vascular Endothelial Growth Factor A | 2004 |
Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Cisplatin; Female; Humans; Laryngeal Neoplasms; Mice; Mice, Nude; Sesquiterpenes; Tumor Burden; Xenograft Model Antitumor Assays | 2006 |
[Inhibition of eIF families expression and angiogenesis for human laryngeal carcinoma by elemene administration].
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Fibroblast Growth Factor 2; Humans; Laryngeal Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Sesquiterpenes; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2005 |
[Elemene in the treatment of the transplantable model of human laryngeal squamous carcinoma in nude mice].
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Line, Tumor; Drugs, Chinese Herbal; Female; Humans; Laryngeal Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phytotherapy; Sesquiterpenes; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-3; Xenograft Model Antitumor Assays | 2007 |